In April 2022, the National Cancer Institute of the United States organized a 3-day seminar, dedicated to boron neutron capture therapy (BNCT). This short article summarizes a presentation from that event, which is intended to provide an overview of activities currently underway worldwide to make BNCT available for patient treatments. This overview does not claim to be exhaustive but shows a great deal of activity in all areas necessary for the complex therapy that is BNCT. A rapid increase in the number of BNCT centers can be expected over the next few years, coupled with the introduction of novel drugs for BNCT. It will be a major challenge to all stakeholders to create clinical networks that can conduct the necessary prospective clinical trials in a short time and in high quality.

中文翻译：

---

2022年硼中子俘获疗法概述

2022 年 4 月，美国国家癌症研究所组织了为期 3 天的研讨会，专门讨论硼中子俘获疗法 (BNCT)。这篇简短的文章总结了该活动的演讲，旨在概述目前全球范围内为使 BNCT 可用于患者治疗而开展的活动。该概述并未声称详尽无遗，但显示了 BNCT 复杂治疗所需的所有领域的大量活动。预计未来几年 BNCT 中心的数量将迅速增加，同时引入用于 BNCT 的新药。创建能够在短时间内高质量进行必要的前瞻性临床试验的临床网络将是所有利益相关者面临的重大挑战。